Will My Insurance Pay for Rehab?
Sponsored adThis sponsor paid to have this advertisement placed in this section.
Are Cannabinoids A Possible Treatment For Aggressive Behavior?

Sponsored adThis sponsor paid to have this advertisement placed in this section.
According to a 2015 study published by the National Center for Biotechnology Information, the cannabinoids in marijuana significantly mitigate aggressive behavior in animal studies. The main objective of the Spanish study was, “To examine the role of cannabinoid CB2r in social and aggressive behavior.”
Using mice as test subjects, scientists from the University of Valencia in Spain examined the effects of the activation of the CB2r cannabinoid receptors in their animal models. The study found that such activation played a critical role in the management of antagonistic conduct. By demonstrating a significant reduction in aggression, the results of the study provide a big step in proving what many already intuitively believed.
Sponsored adThis sponsor paid to have this advertisement placed in this section.
In their research, the scientists discovered that lab mice deficient in CB2r, “Exhibited higher levels of aggression in their social interaction test and displayed more aggression than the study’s resident wild mice ... Acute administration of the CB2r agonist significantly reduced the level of aggression in hostile mice.”
When a social interaction test was performed on mice lacking the cannabinoid receptors, the effects of the CB2r selective agonist was shown to significantly reduce aggression in those lab mice, particularly when compared to their “wild-type littermates.” The study’s overall conclusion is encouraging. “Our results suggest that CB2r is implicated in social interaction and aggressive behavior and deserves further consideration,” researchers said.
As such studies continue to produce positive results, the push for cannabinoids to be rescheduled within the controlled substance act will gain in momentum. While all healthy mammals have a tendency to act out aggressively from time-to-time, the authors hope their findings will lead to further research on CB2r receptors as a “potential target in the management of aggression-related psychiatric disorders.”